Jagsonpal Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has filed a routine compliance certificate with BSE and NSE for the quarter ended December 31, 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, MCS Share Transfer Agent Limited. It confirms that physical share certificates received for dematerialization during the quarter were duly listed on the stock exchanges, and after verification, the original certificates were cancelled and replaced with the depository's name as the registered owner. This is a standard regulatory requirement under SEBI's 2018 Depositories Regulations.
This is a routine procedural compliance filing with no material impact on the company's operations, financials, or share price. It simply confirms the proper processing of dematerialization requests during the October–December 2025 quarter.